Covered removable self-expandable metal [corrected] stents for the treatment of refractory benign biliary disease

J Dig Dis. 2012 Sep;13(9):486-90. doi: 10.1111/j.1751-2980.2012.00615.x.

Abstract

Objective: The aim of the study was to verify the use of covered removable self-expandable metal stents (CRSEMS) in benign biliary disease after a failure of traditional endoscopic treatment.

Methods: A total of 23 patients who failed traditional endoscopic therapy were enrolled in the study and treated with CRSEMS.

Results: Among all the patients, 11 had a bile leak and 12 suffered benign biliary stenosis. Technical success and immediate clinical success were achieved in all the patients. The overall long-term clinical success rate after stent removal was 100%. The CRSEMS were left in place for a median of 47 days (range 30-240 days). Immediate complications occurred in one patient, stent migration in two and overgrowth of inflammatory tissue in the stent in two.

Conclusion: CRSEMS is an excellent treatment option for patients with benign biliary disease.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Bile Duct Diseases / therapy*
  • Cholangiopancreatography, Endoscopic Retrograde
  • Female
  • Humans
  • Male
  • Metals
  • Middle Aged
  • Stents*

Substances

  • Metals